CYAD - Celyad Oncology GAAP EPS of -Euro0.62 August, 05 2022 01:09 AM Celyad SA Celyad Oncology press release ( NASDAQ: CYAD ): 1H GAAP EPS of -€0.62. As of June 30, 2022, the Company had cash and cash equivalents of €14.4 million Shares -5% AH For further details see: Celyad Oncology GAAP EPS of -€0.62